Get started
Author

Noritaka Machii

Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study
2020 · Hayato Tanabe, Haruka Saito, et al. · Journal of Clinical Medicine · 118
PDF
Effect of Empagliflozin on Endothelial Function in Patients With Type 2 Diabetes and Cardiovascular Disease: Results from the Multicenter, Randomized, Placebo-Controlled, Double-Blind EMBLEM Trial
2019 · Atsushi Tanaka, Michio Shimabukuro, et al. · Diabetes Care · 61
High FIB4 index is an independent risk factor of diabetic kidney disease in type 2 diabetes
2021 · Haruka Saito, Hayato Tanabe, et al. · Scientific Reports · 48
PDF
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
2022 · Atsushi Tanaka, Masataka Sata, et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 33
PDF
Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Atsushi Tanaka, Michio Shimabukuro, et al. · Cardiovascular Diabetology · 32
PDF
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo‐controlled double‐blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi‐center placebo‐controlled double‐blind randomized trial
2020 · Atsushi Tanaka, Michio Shimabukuro, et al. · Journal of Diabetes Investigation · 26
Fast walking is a preventive factor against new-onset diabetes mellitus in a large cohort from a Japanese general population
2021 · Mariko Iwasaki, Akihiro Kudo, et al. · Scientific Reports · 22
PDF
Walking Speed is the Sole Determinant Criterion of Sarcopenia of Mild Cognitive Impairment in Japanese Elderly Patients with Type 2 Diabetes Mellitus
2020 · Noritaka Machii, Akihiro Kudo, et al. · Journal of Clinical Medicine · 21
PDF
Canagliflozin independently reduced plasma volume from conventional diuretics in patients with type 2 diabetes and chronic heart failure: a subanalysis of the CANDLE trial
2022 · Kazuki Shiina, Hirofumi Tomiyama, et al. · Hypertension Research · 14
The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
2016 · Hiroyuki Hirai, Emi Ogata, et al. · Journal of Medical Case Reports · 13
PDF
Blood pressure reduction with empagliflozin in Japanese patients with type 2 diabetes and cardiovascular diseases: a post-hoc sub-analysis of the placebo-controlled randomized EMBLEM trial
2024 · Atsushi Tanaka, Michio Shimabukuro, et al. · Hypertension Research · 8
Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial
2023 · Yuichi Saito, Atsushi Tanaka, et al. · Hypertension Research · 8
PDF
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
2023 · Shinji Kishimoto, Yukihito Higashi, et al. · Cardiovascular Diabetology · 6
PDF
Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study
2023 · Akihiro Kudo, Noritaka Machii, et al. · BMJ Open Diabetes Research & Care · 6
PDF
Burden of Undiagnosed Type 2 Diabetes in Diabetic Kidney Disease: A Japanese Retrospective Cohort Study
2020 · Hayato Tanabe, Haruka Saito, et al. · Journal of Clinical Medicine · 4
PDF
Walking Speed is the Sole Determinant of mild Cognitive Impairment in Japanese Patients with Type 2 Diabetes Mellitus
2020 · Noritaka Machii, Akihiro Kudo, et al. · 4
PDF
Resistin Exacerbates Insulin Resistance under the Condition of Low Adiponectin in 3T3-L1 Adipocytes
2012 · Noritaka Machii · Journal of Diabetes & Metabolism · 3
PDF
Vasospastic Angina in Identical Twins
2007 · Noritaka Machii, Goro Ishida, et al. · Nihon Naika Gakkai Zasshi · 1
PDF
MOESM3 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM1 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM2 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
MOESM4 of Rationale and design of a multicenter placebo-controlled double-blind randomized trial to evaluate the effect of empagliflozin on endothelial function: the EMBLEM trial
2017 · Tanaka, Atsushi, Shimabukuro, Michio, et al. · Figshare
Works count: 26
Citation count: 428
H-index: 10
I10-index: 10
Year
Topic
Type